BaseSpace
Correlation
Engine-Public
Sign In
Register
Correlation Engine 2.0
Home
My Data
Bookmarks
Collaborations
Inbox
Import Your Data
QuickView
FAQ
What is QuickView?
What can my QuickView results tell me?
What are the sources for the General Info tab in QuickView?
More QuickView FAQs
Back to top
QuickView
Curated
Studies
Body
Atlas
Disease
Atlas
Pharmaco
Atlas
Knockdown
Atlas
Genetic
Markers
Pathway
Enrichment
Literature
Clinical
Trials
0
Meta-
Analysis
QuickView
Search sequence regions
(e.g.
Lipitor
,
rs2230926
,
ERBB2
,
Angiogenesis
,
HIV infection
,
Intestine
,
Amniocentesis
)
Organisms
Chromosomes
Start
Stop
Homo Sapiens
Mus Musculus
Rattus Norvegicus
C. Elegans
D. Melanogaster
Saccharomyces Cerevisiae
QuickView
Go back to main search
Bookmark
Forward
QuickView
for
Slx4
(gene)
Summary
General Info
Body Atlas
Most Correlated Tissues
Ascending colon
Testes
Transverse colon
Cerebellum
Rectum colon
Explore Body Atlas Results
Disease Atlas
Most Correlated Diseases
Rhinitis
Platelet count below reference range
Platelet disorder
Disease due to Orthopoxvirus
Behavior finding
Explore Disease Atlas Results
Pharmaco Atlas
Most Correlated Compounds
Buformin
fasudil
Deoxyglucose
Electromagnetic Radiation
hydroquinone
Explore Pharmaco Atlas Results
Knockdown Atlas
Most Correlated Gene Perturbations
CAVIN1
C15orf65
CIITA
ISLR
ACTN4
Explore Knockdown Atlas Results
Curated Studies
Most Correlated Studies
Loading...
Explore Curated Studies Results
Literature
Most Relevant Literature
Mammalian BTBD12 (SLX4) protects against genomic instability during mammalian spermatogenesis.
Drosophila MUS312 and the vertebrate ortholog BTBD12 interact with DNA structure-specific endonuclea…
Mammalian BTBD12/SLX4 assembles a Holliday junction resolvase and is required for DNA repair.
Disruption of mouse Slx4, a regulator of structure-specific nucleases, phenocopies Fanconi anemia.
Coordination of structure-specific nucleases by human SLX4/BTBD12 is required for DNA repair.
Explore Literature Results
Clinical Trials
Most Relevant Clinical Trials
Comprehensive Analysis of Predictors of the Treatment With Pembrolizumab and Olaparib in Patients Wi…
Study of SBRT/Olaparib Followed by Pembrolizumab/Olaparib in Gastric Cancers
A Trial of Niraparib in BAP1 and Other DNA Damage Response (DDR) Deficient Neoplasms (UF-STO-ETI-001…
Niraparib Plus Carboplatin in Patients With Homologous Recombination Deficient Advanced Solid Tumor …
A Study of Niraparib in People With Soft Tissue Sarcoma Who Have Changes in Their Tumor DNA
Explore Clinical Trials Results
search
→
result
search
→
result
See more about this page
See complete FAQ